Ilya Zubkov
Stock Analyst at Freedom Broker
(2.23)
# 3,189
Out of 5,182 analysts
77
Total ratings
46.77%
Success rate
-3.7%
Average return
Main Sectors:
Stocks Rated by Ilya Zubkov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Initiates: Buy | $12 | $7.35 | +63.27% | 1 | Apr 7, 2026 | |
| ANGO AngioDynamics | Initiates: Buy | $16 | $10.98 | +45.72% | 1 | Apr 6, 2026 | |
| IRMD IRADIMED CORPORATION | Initiates: Buy | $116 | $84.49 | +37.29% | 1 | Apr 2, 2026 | |
| LFMD LifeMD | Maintains: Buy | $8 → $10 | $4.55 | +119.78% | 4 | Mar 12, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $100 → $105 | $53.30 | +97.00% | 2 | Mar 2, 2026 | |
| BFLY Butterfly Network | Maintains: Buy | $5 → $5.5 | $5.16 | +6.59% | 2 | Mar 2, 2026 | |
| LGCY Legacy Education | Maintains: Buy | $13 → $15 | $11.21 | +29.35% | 4 | Feb 24, 2026 | |
| BIIB Biogen | Maintains: Hold | $160 → $185 | $183.38 | +0.88% | 3 | Feb 23, 2026 | |
| LFVN LifeVantage | Maintains: Buy | $17 → $11 | $5.19 | +111.95% | 4 | Feb 18, 2026 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | $470 → $410 | $302.11 | +35.71% | 2 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $245 → $260 | $197.69 | +31.52% | 3 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $36 | $25.74 | +39.86% | 4 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $360 → $375 | $339.57 | +10.43% | 2 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1,050 → $1,200 | $874.00 | +37.30% | 4 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $110 | $110.03 | -0.03% | 3 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $33 | $26.48 | +24.62% | 2 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $130 → $120 | $93.86 | +27.85% | 1 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $190 → $220 | $227.79 | -3.42% | 4 | Jan 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $610 | $466.64 | +30.72% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $16 → $4 | $4.76 | -15.97% | 4 | Jan 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $9.26 | -2.81% | 1 | Dec 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.88 | +59.57% | 1 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $1 | $2.78 | -64.03% | 2 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $6.20 | +125.81% | 2 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $15 | $5.08 | +195.28% | 2 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $4.5 | $1.14 | +294.74% | 3 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $38 | $39.59 | -4.02% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $2.70 | +122.22% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $9.5 → $1 | $0.79 | +26.01% | 1 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $3.01 | +199.00% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $3.89 | +105.66% | 2 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $4 | $1.40 | +185.71% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $14 → $37 | $21.07 | +75.61% | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $15 → $1.5 | $5.17 | -70.99% | 1 | May 16, 2025 |
Inogen
Apr 7, 2026
Initiates: Buy
Price Target: $12
Current: $7.35
Upside: +63.27%
AngioDynamics
Apr 6, 2026
Initiates: Buy
Price Target: $16
Current: $10.98
Upside: +45.72%
IRADIMED CORPORATION
Apr 2, 2026
Initiates: Buy
Price Target: $116
Current: $84.49
Upside: +37.29%
LifeMD
Mar 12, 2026
Maintains: Buy
Price Target: $8 → $10
Current: $4.55
Upside: +119.78%
BioMarin Pharmaceutical
Mar 2, 2026
Maintains: Buy
Price Target: $100 → $105
Current: $53.30
Upside: +97.00%
Butterfly Network
Mar 2, 2026
Maintains: Buy
Price Target: $5 → $5.5
Current: $5.16
Upside: +6.59%
Legacy Education
Feb 24, 2026
Maintains: Buy
Price Target: $13 → $15
Current: $11.21
Upside: +29.35%
Biogen
Feb 23, 2026
Maintains: Hold
Price Target: $160 → $185
Current: $183.38
Upside: +0.88%
LifeVantage
Feb 18, 2026
Maintains: Buy
Price Target: $17 → $11
Current: $5.19
Upside: +111.95%
Alnylam Pharmaceuticals
Feb 17, 2026
Upgrades: Buy
Price Target: $470 → $410
Current: $302.11
Upside: +35.71%
Feb 17, 2026
Maintains: Buy
Price Target: $245 → $260
Current: $197.69
Upside: +31.52%
Feb 12, 2026
Maintains: Buy
Price Target: $34 → $36
Current: $25.74
Upside: +39.86%
Feb 12, 2026
Downgrades: Hold
Price Target: $360 → $375
Current: $339.57
Upside: +10.43%
Feb 10, 2026
Upgrades: Buy
Price Target: $1,050 → $1,200
Current: $874.00
Upside: +37.30%
Feb 9, 2026
Maintains: Hold
Price Target: $90 → $110
Current: $110.03
Upside: -0.03%
Feb 9, 2026
Maintains: Buy
Price Target: $35 → $33
Current: $26.48
Upside: +24.62%
Jan 29, 2026
Upgrades: Buy
Price Target: $130 → $120
Current: $93.86
Upside: +27.85%
Jan 27, 2026
Maintains: Hold
Price Target: $190 → $220
Current: $227.79
Upside: -3.42%
Jan 26, 2026
Upgrades: Buy
Price Target: $560 → $610
Current: $466.64
Upside: +30.72%
Jan 21, 2026
Downgrades: Sell
Price Target: $16 → $4
Current: $4.76
Upside: -15.97%
Dec 30, 2025
Initiates: Buy
Price Target: $9
Current: $9.26
Upside: -2.81%
Dec 17, 2025
Initiates: Buy
Price Target: $3
Current: $1.88
Upside: +59.57%
Nov 21, 2025
Maintains: Buy
Price Target: $2 → $1
Current: $2.78
Upside: -64.03%
Nov 21, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $6.20
Upside: +125.81%
Nov 20, 2025
Maintains: Buy
Price Target: $11 → $15
Current: $5.08
Upside: +195.28%
Nov 20, 2025
Maintains: Buy
Price Target: $22 → $4.5
Current: $1.14
Upside: +294.74%
Oct 17, 2025
Initiates: Buy
Price Target: $38
Current: $39.59
Upside: -4.02%
Oct 1, 2025
Initiates: Buy
Price Target: $6
Current: $2.70
Upside: +122.22%
Sep 19, 2025
Downgrades: Hold
Price Target: $9.5 → $1
Current: $0.79
Upside: +26.01%
Sep 17, 2025
Initiates: Buy
Price Target: $9
Current: $3.01
Upside: +199.00%
Aug 15, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $3.89
Upside: +105.66%
Aug 12, 2025
Maintains: Buy
Price Target: $7 → $4
Current: $1.40
Upside: +185.71%
Aug 11, 2025
Upgrades: Buy
Price Target: $14 → $37
Current: $21.07
Upside: +75.61%
May 16, 2025
Downgrades: Hold
Price Target: $15 → $1.5
Current: $5.17
Upside: -70.99%